Dr. Kudchadkar is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1365 Clifton Rd Ne
2nd Floor
Atlanta, GA 30322Phone+1 813-745-8581
Education & Training
University of ColoradoFellowship, Hematology and Medical Oncology, 2006 - 2009
Emory University School of MedicineResidency, Internal Medicine, 2003 - 2006- Emory University School of MedicineClass of 2003
Certifications & Licensure
GA State Medical License 2013 - 2023
FL State Medical License 2009 - 2015
CO State Medical License 2006 - 2011- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Pembrolizumab in Patients With Locally Advanced or Metastatic Skin Cancer Start of enrollment: 2017 Jan 27
- Cemiplimab Before and After Surgery for the Treatment of High Risk Cutaneous Squamous Cell Cancer Start of enrollment: 2020 May 15
Publications & Presentations
PubMed
- Cutaneous and Noncutaneous Adverse Effects in Patients with Advanced Melanoma Receiving Immunotherapy.Howa Yeung, Krittin J Supapannachart, Sandy Francois, Colin H Adler, Ragini R Kudchadkar
JID Innovations. 2023-11-01 - 8 citationsFcγRIIB expressed on CD8T cells limits responsiveness to PD-1 checkpoint inhibition in cancer.Kelsey B Bennion, Marvi Tariq, Megan M Wyatt, Charlotte Duneton, Kirsten M Baecher
Science Translational Medicine. 2023-08-23 - 3 citationsPhase II clinical and immune correlate study of adjuvant nivolumab plus ipilimumab for high-risk resected melanoma.Nikhil I Khushalani, Melinda Vassallo, Judith D Goldberg, Zeynep Eroglu, Younchul Kim
Journal for Immunotherapy of Cancer. 2022-11-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
